Tower Research Capital LLC (Trc) Actinium Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,978 shares of ATNM stock, worth $5,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,978

Previous 5,263 24.42%

Holding current value

$5,171

Previous $38,000 81.58%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.72 - $8.0 $2,210 - $10,280	-1,285 Reduced 24.42%	3,978 $7,000
Q2 2024 Aug 13, 2024	BUY	$6.56 - $9.89 $19,122 - $28,829	2,915 Added 124.15%	5,263 $38,000
Q1 2024 May 15, 2024	BUY	$5.0 - $9.2 $1,250 - $2,300	250 Added 11.92%	2,348 $18,000
Q4 2023 Feb 13, 2024	SELL	$4.02 - $6.08 $1,141 - $1,726	-284 Reduced 11.92%	2,098 $10,000
Q3 2023 Nov 14, 2023	BUY	$5.91 - $7.37 $8,291 - $10,340	1,403 Added 143.31%	2,382 $14,000
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.39 $4,597 - $6,037	643 Added 191.37%	979 $7,000
Q1 2023 May 09, 2023	SELL	$8.51 - $14.26 $851 - $1,426	-100 Reduced 22.94%	336 $3,000
Q4 2022 Feb 10, 2023	SELL	$7.05 - $14.41 $29,109 - $59,498	-4,129 Reduced 90.45%	436 $5,000
Q3 2022 Nov 10, 2022	SELL	$4.81 - $8.48 $5,969 - $10,523	-1,241 Reduced 21.37%	4,565 $33,000
Q2 2022 Aug 15, 2022	BUY	$4.71 - $7.11 $22,471 - $33,921	4,771 Added 460.97%	5,806 $28,000
Q1 2022 May 12, 2022	BUY	$4.57 - $6.4 $607 - $851	133 Added 14.75%	1,035 $6,000
Q4 2021 Feb 14, 2022	BUY	$6.01 - $8.8 $4,219 - $6,177	702 Added 351.0%	902 $5,000
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.67 $20,782 - $34,889	-3,608 Reduced 94.75%	200 $2,000
Q2 2021 Aug 16, 2021	BUY	$7.01 - $8.63 $13,297 - $16,371	1,897 Added 99.27%	3,808 $30,000
Q1 2021 May 17, 2021	BUY	$7.62 - $9.79 $14,561 - $18,708	1,911 New	1,911 $15,000
Q4 2020 Feb 16, 2021	SELL	$7.8 - $12.64 $11,551 - $18,719	-1,481 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.26 - $18.0 $10,752 - $26,658	1,481 New	1,481 $14,000

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.35M

Call Options Held

65.2K

Put Options Held

21.7K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $32.7M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Actinium Pharmaceuticals, Inc. Transaction History